So practically no teenagers have kids (a good thing). Very few women in their early 20s having kids (probably also a good thing). Age of marriage and family formation rising (also a good thing for ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback